OptiNose Reconciled Depreciation from 2010 to 2024

OPTN Stock  USD 0.50  0.01  1.96%   
OptiNose Reconciled Depreciation yearly trend continues to be very stable with very little volatility. Reconciled Depreciation is likely to grow to about 761.7 K this year. During the period from 2010 to 2024, OptiNose Reconciled Depreciation quarterly data regression pattern had sample variance of 160.8 B and median of  164,000. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2016-09-30
Previous Quarter
83 K
Current Value
70 K
Quarterly Volatility
114.6 K
 
Covid
Check OptiNose financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OptiNose's main balance sheet or income statement drivers, such as Interest Income of 2.7 M, Depreciation And Amortization of 611.7 K or Interest Expense of 10.9 M, as well as many indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0461 or Days Sales Outstanding of 97.33. OptiNose financial statements analysis is a perfect complement when working with OptiNose Valuation or Volatility modules.
  
Check out the analysis of OptiNose Correlation against competitors.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.

Latest OptiNose's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of OptiNose over the last few years. It is OptiNose's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OptiNose's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

OptiNose Reconciled Depreciation Regression Statistics

Arithmetic Mean450,445
Geometric Mean325,096
Coefficient Of Variation89.04
Mean Deviation312,000
Median164,000
Standard Deviation401,058
Sample Variance160.8B
Range1.3M
R-Value0.62
Mean Square Error107.1B
R-Squared0.38
Significance0.01
Slope55,424
Total Sum of Squares2.3T

OptiNose Reconciled Depreciation History

2024761.7 K
2023402 K
2022532 K
2021646 K
20201.5 M
20191.1 M
2018539 K

About OptiNose Financial Statements

OptiNose investors utilize fundamental indicators, such as Reconciled Depreciation, to predict how OptiNose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Reconciled Depreciation402 K761.7 K

Pair Trading with OptiNose

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OptiNose position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will appreciate offsetting losses from the drop in the long position's value.

Moving together with OptiNose Stock

  0.84JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.8LLY Eli LillyPairCorr

Moving against OptiNose Stock

  0.82BMY Bristol Myers SquibbPairCorr
  0.68CAH Cardinal HealthPairCorr
  0.59ESPR Esperion TherapeuticsPairCorr
  0.59XAIR Beyond AirPairCorr
  0.53GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to OptiNose could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OptiNose when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OptiNose - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OptiNose to buy it.
The correlation of OptiNose is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OptiNose can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out the analysis of OptiNose Correlation against competitors.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
0.553
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.